top of page

Long-acting antipsychotic medication in schizophrenia

A correct dose of anti-psychotic medication in schizophrenia patients has a positive effect on remission and decreases the risk of relapse. However, almost half of the patients fail to adhere to drug description, resulting in relapse. This project aims to map the use of anti-psychotic medication and investigates the effects on disease progression. 

Funding: PZ Duffel, CAPRI, UMC Utrecht

Researcher:

Sarah Debruyne

sarah.debruyne@emmaus.be

  • Instagram
  • Facebook
  • LinkedIn
  • YouTube

© 2026 by SINAPS 

logo sinaps clear background square.png
bottom of page